Vulpes vulpes

@bubu12
 

bubu12 : Une fois ces infos sous le nez, vous bifurquez sur les enfants, quel rapport puisqu’on ne vaccine pas les enfants. Vous faites preuve de manipulation et de malhonnêteté. 

"Children under 18 make up 85 million people in [the] U.S. - about 20% of the population," Dr. Yvonne Maldonado, professor of pediatrics, epidemiology and population health at Stanford University, told ABC News. "Getting them vaccinated is a major contribution to reducing transmission of virus."

Pfizer’s study involves 5,000 kids nationwide and they say they hope to have results by the winter.

Children as young as 6 months old now in COVID-19 vaccine trials

Moderna Announces First Participants Dosed in Phase 2/3 Study of COVID-19 Vaccine Candidate in Pediatric Population

The Company intends to enroll approximately 6,750 pediatric participants in the U.S. and Canada ages 6 months to less than 12 years.

Est-ce que la vie de 11.750 enfants, entre six mois et 12 ans compte pour vous ???

@bubu12
 

bubu12 1er mai 

Vous affirmez que les vaccins commercialisés en France sont toujours en phase 3, que ce n’est pas normal. Or à qui sont destinés ces vaccins ? aux adultes. L’essai de phase 3 de Pfizer sur les adultes est terminé et publié.

 19 February 2021 EMA/707383/2020 Corr.1*1 Committee for Medicinal Products for Human Use (CHMP) Assessment report Comirnaty Common name : COVID-19 mRNA vaccine (nucleoside-modified) Procedure No. EMEA/H/C/005735/0000

Missing information

Since pregnant and breast-feeding women were excluded from the study, no information is available for those populations. It is agreed to include use during pregnancy and while breastfeeding as missing information in the RMP.

At the data cut-off of 14 Nov-20, 10-14 weeks safety data are available. Thus, long-term safety is included as missing information and will be characterised as part of the continuation of the pivotal clinical trial and the PASS.

Interaction with other vaccines, has not been evaluated in clinical trials and may be of interest to prescribers. As elderly individuals will be one target group for vaccination, and they often may need vaccination with other vaccines such as influenza and pneumococcus vaccines, further data is requested. The Applicant commits to conduct a study of the co-administration of Comirnaty with inactivated quadrivalent influenza vaccine.

Data from use in frail patients with co-morbidities (e.g. chronic obstructive pulmonary disease (COPD), diabetes, chronic neurological disease, cardiovascular disorders), is limited, and it is desirable to gather further data in these groups. Therefore, use in frail patients with co-morbidities (e.g. chronic obstructive pulmonary disease (COPD), diabetes, chronic neurological disease, cardiovascular disorders) has been included as missing information in the RMP. Furthermore, information is limited on the use in patients with autoimmune or inflammatory disorders, as well as in immunocompromised patients. Thus, these groups are also included as missing information. Such missing information will be collected in the post-authorisation safety studies.

 

The Applicant proposes 6 interventional studies, of which 2 are ongoing and 4 are planned.

@bubu12
 

bubu12 : mais ca ne veut pas dire que le produit (le vaccin) est mauvais. Au passage c’est BioNTech qui a conçue le vaccin

Pourriez-vous préciser quels sont les traitements / médicaments / vaccins mis sur le marché par Biontech® avant l’injection à ARN covid19™ ?

@bubu12
 

bubu12 : oui ils vont continuer de suivre les 43k de volontaires de l’étude de phase 3...

She is part of a trial that began testing the Pfizer–BioNTech vaccine in children under 12 in late March [2021]

 
COVID vaccines and kids : five questions as trials begin 

bubu12  : ensuite quand on vous explique que la phase 3 est publiée vous bifurquez volontairement sur les enfants alors qu’aucun pays dans le monde n’a commencé une campagne de vaccination sur des enfants et que l’essai de phase 3 publié porte sur des adultes.

1. Les essais cliniques de phase 3 sont en cours – je vous laisse consulter les documents officiels à ce sujet

2. La phase 3 est publiée !  C’est absurde ce que vous affirmez.

Je vous suggère de vous renseigner davantage au sujet des essais cliniques de phase 3

3. Les essais cliniques sur les enfants en font partie

4. Je n’ai jamais affirmé qu’il y a une campagne de vaccination en cours sur les enfants

@bubu12
 

bubu12  : vous travestissez les résultats d’un essai car vous ne savez pas ce qu’est un critère de jugement principal ou secondaire

L’article est pourtant clair :

No deaths were considered by the investigators to be related to the vaccine or placebo. No Covid-19–associated deaths were observed.

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

En conclusion, 0 décès dans le bras placebo, 0 décès dans le bras Pfiz€r – rien de bien compliqué à comprendre !